The following was posted on our main message board this morning.
Hugs
Christine
The patient coordinator at the Univesity of Washington called me and informed that Phase I of the clincial trial for the Her2 VAccine for people who are in remission and have not taken Herceptin is opening next month. The criteria is multiple lymph noded involvement. For more information please call Andrea York University of Washington in Seattle: 206/616-9538 email:
AY5@U.Washington.edu